Home > Healthcare > Biotechnology > Biotechnology R&D > CRISPR and Cas Gene Market
CRISPR and Cas Gene Market Share
- Report ID: GMI6286
- Published Date: Jul 2023
- Report Format: PDF
CRISPR and Cas Gene Market Share
Major market players operating in the CRISPR and Cas gene market include
- AstraZeneca plc
- Addgene
- Cellectis
- CRISPR Therapeutics
- Editas Medicine, Inc.
Frequently Asked Questions (FAQ) :
CRISPR and cas gene market size was USD 2.5 billion in 2022 and will reach USD 17.4 billion by end of 2032 due to high prevalence of genetic diseases and complex medical conditions worldwide
The genome engineering application segment recorded 38.5% of the market share in 2022 driven by the rise in R&D activities demonstrating the effectiveness of CRISPR technologies
Biotechnology & pharmaceutical companies is projected to observe 21.2% CAGR from 2023-2032 owing to the rising number of partnerships and collaborations between academic researchers and industry players
North America accounted for 42.3% share of the market in 2022 and is anticipated to foresee considerable growth through 2032 owing to the presence of well-established biotechnology and pharmaceutical sector in the region
CRISPR and Cas Gene Market Scope
×
Get a free sample of
CRISPR and Cas Gene Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below